Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 111
Cardiovascular Drugs 85
Vaccines 47
Central Nervous System Drugs 39
Hematological Drugs 35
Drug Discovery 34
Pharmaceuticals 34
Endocrine and Metabolic Disorders Drugs 30
Immune Disorders Drugs 27
Genomics 25
Musculoskeletal Disorders Drugs 25
Leukemia Drugs 24
Analgesics 24
Infectious Diseases Drugs 23
Biopharmaceuticals 22
Clinical Trials 21
Contrast Media 19
Oncology 17
Skin Cancer Drugs 16
Biotechnology 15
Lung Cancer Drugs 14
Infusions and Injectables 14
Antibiotics 14
Women's Health 13
Enzymes 13
Breast Cancer Drugs 12
Alzheimer's Disease Drugs 12
Diabetes Drugs 11
Liver and Kidney Disorders Drugs 11
Diagnostics 10
Hematology 10
Respiratory Drugs 10
Brain Cancer Drugs 9
Gastrointestinal Drugs 9
Allergy and Immunology 8
Healthcare Services 8
Biosimilars and Biosuperiors 8
Colon Cancer Drugs 7
Ultrasound 6
Cardiology 6
Urological Disorders Drugs 6
Pharmaceutical Manufacturing 6
Animal Pharmaceuticals 5
Optical Disorders Drugs 5
Lymphoma Drugs 5
Infectious Disease Testing 5
Managed Care 5
Stem Cells 5
Thyroid Cancer Drugs 5
Pharmaceutical Intermediates 4
Pulmonary Medicine 4
Neurology 4
Liver Cancer Drugs 4
Ovarian Cancer Drugs 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Medical Devices 4
Drug Delivery 4
Gastroenterology 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Pancreatic Cancer Drugs 3
Pediatrics 3
HIV/AIDS Drugs 3
Company Reports 2
Therapeutic Area 2
Urology and Nephrology 2
Prostate Cancer Drugs 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Neurology Devices 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Anti-Obesity Drugs 2
Palliative Care 2
Bronchitis Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Proteomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Other Healthcare Facilities 1
Nanomedicine 1
Laboratory Equipment 1
Endocrinology 1
Acne Drugs 1
Asthma Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

765 Results (Page 1 of 39)
- Relevance
  Sort by

Bevacizumab Biosimilars Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4016EUR$4,490USD£3,477GBP

Bevacizumab - Biosimilar Insight, 2025

 Report
April 2025
80 Pages
Global

From

€1789EUR$2,000USD£1,549GBP

Investigation Report on China's Levofloxacin Market 2021-2025

 Report
June 2021
China

From

€2326EUR$2,600USD£2,014GBP

Axial Spondyloarthritis (AXSPA) Market - Global Strategic Business Report

 Report
March 2026
182 Pages
Global

From

€5233EUR$5,850USD£4,530GBP

Postmenopausal Osteoporosis Treatment Market - Global Strategic Business Report

 Report
March 2026
278 Pages
Global

From

€5233EUR$5,850USD£4,530GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Levofloxacin Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
April 2023
89 Pages
Global

From

€3500EUR$4,191USD£3,136GBP

Adalimumab-Biosimilars Insight, 2022

 Report
January 2022
90 Pages
Global

From

€1789EUR$2,000USD£1,549GBP

Liraglutide and Semaglutide - Global Strategic Business Report

 Report
March 2026
451 Pages
Global

From

€5233EUR$5,850USD£4,530GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4016EUR$4,490USD£3,477GBP

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026

 Report
March 2026
450 Pages
Global

From

€3574EUR$3,995USD£3,094GBP

Bispecific Antibodies Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Mechanism of Action, Target Antigen Antibody Format, Key Geographical Regions and Key Players

 Report
December 2025
391 Pages
Global

From

€4293EUR$4,799USD£3,717GBP

Cancer Pain Management Market - Global Strategic Business Report

 Report
March 2026
588 Pages
Global

From

€5233EUR$5,850USD£4,530GBP

Postmenopausal Osteoporosis Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4016EUR$4,490USD£3,477GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026

 Report
March 2026
600 Pages
Global

From

€3574EUR$3,995USD£3,094GBP

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2026

 Report
March 2026
300 Pages
Global

From

€3574EUR$3,995USD£3,094GBP

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026

 Report
March 2026
300 Pages
Global

From

€3574EUR$3,995USD£3,094GBP

Fibromyalgia Therapeutics - Global Strategic Business Report

 Report
March 2026
263 Pages
Global

From

€5233EUR$5,850USD£4,530GBP

US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028

 Report
February 2022
360 Pages
United States

From

€3220EUR$3,600USD£2,788GBP

Zollinger-Ellison Syndrome Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4016EUR$4,490USD£3,477GBP

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

 Drug Pipelines
February 2026
3300 Pages
United States

From

€8051EUR$9,000USD£6,970GBP

765 Results (Page 1 of 39)
- 1
- 2
- 3

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.